Close Menu

NEW YORK (GenomeWeb) – DiaSorin Molecular said today that the US Food and Drug Administration has cleared the company's Simplexa VZV Direct assay for detecting varicella-zoster virus.

The assay is for use with cerebrospinal fluid samples and can help in diagnosing meningitis and encephalitis. It requires 50 microliters of CSF per test and can be used with DiaSorin Molecular's Liaison MDx instrument. It also complements the Cypress, California-based firm's Simplexa HSV 1 and 2 Direct assay, the company said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jul
30
Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.